CNBP Antibody [E10D2]

N° de catalogue F5127

Imprimer

Description biologique

Spécificité

CNBP Antibody [E10D2] détecte les niveaux endogènes de la protéine CNBP totale.

Contexte

CNBP (ZNF9) est une protéine de liaison aux acides nucléiques à doigt de zinc de type CCHC hautement conservée, essentielle au développement embryonnaire et à la régulation génique post-transcriptionnelle, caractérisée par sept motifs en tandem de type « zinc knuckle » qui coordonnent les ions zinc pour former des repliements ββα compacts, permettant une liaison de haute affinité aux séquences d'ADN et d'ARN simple brin riches en G. La présence d'une boîte RGG entre le premier et le deuxième doigt de zinc facilite la formation de gouttelettes biomoléculaires séparées en phase et améliore le remodelage coopératif des acides nucléiques. CNBP fonctionne comme une chaperonne de G-quadruplex (G4), dépliant activement les structures G4 stables au sein du promoteur c-Myc pour promouvoir la transcription par l'ARN polymérase II, et au sein de l'UTR 5' de l'ARNm ODC pour faciliter la traduction indépendante de la coiffe. CNBP peut transactiver des gènes tels que la β-caténine et l'IL-6 par une liaison directe au promoteur dépendante du G4, son activité et sa localisation étant dynamiquement régulées par la dimérisation déclenchée par la phosphorylation et la translocation nucléaire en réponse au stress cellulaire et à la signalisation des cytokines. L'expansion des répétitions (CCTG)n dans l'intron 1 de CNBP est à l'origine de la dystrophie myotonique de type 2 (DM2), où les transcrits d'ARN mutants séquestrent le CNBP fonctionnel, entraînant une toxicité de la protéine de type muscleblind, une altération de la myogenèse due à la stabilisation du G4 de myf5 et une atrophie multisystémique progressive.

Informations dutilisation

Application WB, IP Dilution
WB
1:5000-1:50000
Réactivité Mouse, Rat, Human
Source Mouse Monoclonal Antibody MW 19 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:5000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/31219592/
  • https://pubmed.ncbi.nlm.nih.gov/34474118/

Données dapplication

WB

Validé par Selleck

  • F5127-wb
    Lane 1: LNCAP, Lane 2: Hela, Lane 3: Jurkat, Lane 4: NIH/3T3